Correlation Between Gain Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Gain Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Gain Therapeutics and Lyra Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gain and Lyra is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Gain Therapeutics is expected to generate 0.83 times more return on investment than Lyra Therapeutics. However, Gain Therapeutics is 1.2 times less risky than Lyra Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 318.00 in Gain Therapeutics on August 29, 2024 and sell it today you would lose (144.00) from holding Gain Therapeutics or give up 45.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| Gain Therapeutics |
| Lyra Therapeutics |
Gain Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Gain Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Gain Therapeutics vs. Biovie Inc | Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. NewAmsterdam Pharma | Gain Therapeutics vs. Cue Biopharma |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |